Over the past 12 months, Turn Therapeutics insiders bought $308,460 of stock on the open market (77.39K shares) and made no open-market sales.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Bradley Evan Burnam | Chief Executive Officer | 0 | 15,416,260 | 15,416,260 | 89.2% | 01 Jun, 2026 |
| 2 | Abraham Chesed | Other | 0 | 1,447,268 | 1,447,268 | 8.4% | 29 Oct, 2025 |
| 3 | Arthur F Golden | Director | 360,602 | 0 | 360,602 | 2.1% | 03 Apr, 2026 |
| 4 | Martin William Dewhurst | Director | 21,882 | 0 | 21,882 | 0.1% | 04 Feb, 2026 |
| 5 | Zuraiz Chaudhary | Officer | 12,500 | 0 | 12,500 | 0.1% | 12 Dec, 2025 |
| 6 | Kent Edward Kester | Director | 10,000 | 0 | 10,000 | 0.1% | 10 Oct, 2025 |
| 7 | Neilesh Shailesh Ghodadra | Chief Medical Officer | 10,000 | 0 | 10,000 | 0.1% | 10 Oct, 2025 |
| 8 | Andrew Gengos | Director | 10,000 | 0 | 10,000 | 0.1% | 10 Oct, 2025 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 04 Jun, 2026 | Arthur F Golden | Director | Acquired A | 89,584 | $0.00 | $0 | 89,584 | Direct |
| 04 Jun, 2026 | Andrew Gengos | Director | Acquired A | 95,000 | $0.00 | $0 | 95,000 | Direct |
| 04 Jun, 2026 | Kent Edward Kester | Director | Acquired A | 83,334 | $0.00 | $0 | 83,334 | Direct |
| 04 Jun, 2026 | Martin William Dewhurst | Director | Acquired A | 71,666 | $0.00 | $0 | 71,666 | Direct |
| 28 May, 2026 | Bradley Evan Burnam | Chief Executive Officer | Disposed G | 300,000 | $0.00 | $0 | 15,416,260 | Indirect |
| 28 May, 2026 | Bradley Evan Burnam | Chief Executive Officer | Acquired G | 300,000 | $0.00 | $0 | 300,000 | Indirect |
| 28 May, 2026 | Bradley Evan Burnam | Chief Executive Officer | Disposed G | 300,000 | $0.00 | $0 | 15,116,260 | Indirect |
| 28 May, 2026 | Bradley Evan Burnam | Chief Executive Officer | Acquired G | 300,000 | $0.00 | $0 | 300,000 | Indirect |
| 02 Apr, 2026 | Bradley Evan Burnam | Chief Executive Officer | Disposed G | 300,000 | $0.00 | $0 | 15,716,260 | Indirect |
| 01 Apr, 2026 | Bradley Evan Burnam | Chief Executive Officer | Acquired A | 160,000 | $0.00 | $0 | 160,000 | Direct |
| 01 Apr, 2026 | Zuraiz Chaudhary | Officer | Acquired A | 80,000 | $0.00 | $0 | 80,000 | Direct |
| 02 Apr, 2026 | Arthur F Golden | Director | Acquired G | 300,000 | $0.00 | $0 | 360,602 | Direct |
| 07 Jan, 2026 | Martin William Dewhurst | Director | Acquired A | 21,882 | $0.00 | $0 | 21,882 | Direct |
| 12 Dec, 2025 | Zuraiz Chaudhary | Officer | Acquired P | 2,500 | $3.50 | $8.75K | 12,500 | Direct |
| 24 Nov, 2025 | Arthur F Golden | Director | Acquired P | 9,868 | $3.44 | $33.95K | 60,602 | Direct |
| 21 Nov, 2025 | Arthur F Golden | Director | Acquired P | 20,532 | $2.87 | $58.93K | 50,734 | Direct |
| 20 Nov, 2025 | Zuraiz Chaudhary | Officer | Acquired P | 1,450 | $2.61 | $3.78K | 9,000 | Direct |
| 21 Nov, 2025 | Zuraiz Chaudhary | Officer | Acquired P | 1,000 | $3.29 | $3.29K | 10,000 | Direct |
| 17 Nov, 2025 | Zuraiz Chaudhary | Officer | Acquired P | 2,500 | $3.62 | $9.05K | 7,550 | Direct |
| 23 Oct, 2025 | Abraham Chesed | Other | Acquired P | 14,286 | $4.60 | $65.72K | 1,447,268 | Indirect |